Institute of Immunology Zagreb

The Institute of Immunology is the oldest manufacturer of immunobiological medicines in this part of Europe. Since 1893 and our vaccine against small-pox until today’s viral and bacterial vaccines, products from human and equine plasma, allergens and other products, our aim remains the same: PREVENTION AND FIGHTING DISEASE

Let me Introduce a new and modern concept of the websites relying on the great tradition and looking to the future. Here you can learn all about our products, our work of special importance to human health, our visions on research and development. Familiarize yourself with our ownership structure, financial reports and guidelines of further development and goals. ...continuation of the introduction

view all NEWS

02/23/2012

Despite the pronounced recession, after several years of business with financial loss and loss in 2010 of 12.6 million HRK, Institute of Immunology in 2011 was operated with a profit of almost half a million HRK. This is the result of rational operations, financial consolidation and the ongoing process of restructuring the Institute

02/14/2012

Researchers from the Institute of Immunology in collaboration with researchers from the Ruđer Bošković Institute and Vienna University of Technology have published a paper entitled Chromatography, mass spectrometry, and molecular modeling studies on ammodytoxins in Analytical and Bioanalytical Chemistry journal (IF 3,841)

Results

The Institute, with its technology, products and expert personnel can compete in the market for viral vaccines on a global scale and for plasma fractionation on a regional level.

Goals

Getting started in new facilities
Multiple capacity increase
Satisfy GMP requirements

Development

The main goal of our research and development is to develop new biotechnical products with high added value. Our research potential is focused on the development of new vaccines and blood plasma preparations.